VivoSim Labs 8-K: Nasdaq Compliance, $10.1M Cash, 500%+ FY27 Growth

What Happened
VivoSim Labs, Inc. filed an 8-K on August 6, 2026, disclosing a press release that the Nasdaq Listing Qualifications Staff determined the company currently complies with Nasdaq Listing Rule 5550(b)(1) (minimum stockholders’ equity of $2.5M). The company reported preliminary cash on hand of approximately $10.1 million as of August 3, 2026, and announced it anticipates more than 500% revenue growth in fiscal year 2027. The numbers are preliminary and based on management’s current estimates.

Key Details

• Nasdaq compliance: Listing Qualifications Staff determined VivoSim meets Nasdaq Rule 5550(b)(1) (minimum $2.5M stockholders’ equity).
• Cash position: Preliminary cash on hand ≈ $10.1 million as of August 3, 2026.
• Growth outlook: Company anticipates 500%+ revenue growth in fiscal year 2027.
• Filing/press release: Information disclosed via press release furnished as Exhibit 99.1 in the 8-K; estimates may change after closing procedures and final adjustments.
• Report signed by Norman Staskey, Chief Financial Officer, dated August 6, 2026.

Why It Matters
For investors, the filing signals that VivoSim has restored/maintained the minimum equity required by Nasdaq, reducing near-term listing-risk concerns. The reported ~$10.1M cash balance indicates available liquidity, while the company’s aggressive 500%+ FY2027 revenue projection, if realized, would materially change revenue trajectory. Note that the cash figure and growth outlook are preliminary estimates and subject to final closing adjustments, so investors should look for audited results and later filings for confirmation.